Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Do rheumatology cost-effectiveness analyses make sense?

× No keyword cloud information.

6 in total

1. [Are "biologics" in the treatment of rheumatoid arthritis really cost effective?].

Authors: U Müller-Ladner
Journal: Internist (Berl) Date: 2004-12 Impact factor: 0.743

Review 2. Introduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis.

Authors: Carlo A Marra; Nick Bansback; Aslam H Anis; Kamran Shojania
Journal: Clin Rheumatol Date: 2011-02-26 Impact factor: 2.980

Review 3. An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.

Authors: Nick J Bansback; Dean A Regier; Roberta Ara; Alan Brennan; Kamran Shojania; John M Esdaile; Aslam H Anis; Carlo A Marra
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 4. Etanercept: a pharmacoeconomic review of its use in rheumatoid arthritis.

Authors: Katherine A Lyseng-Williamson; Greg L Plosker
Journal: Pharmacoeconomics Date: 2004 Impact factor: 4.981

Review 5. Health economics: implications for novel antirheumatic therapies.

Authors: A Kavanaugh
Journal: Ann Rheum Dis Date: 2005-11 Impact factor: 19.103

6. Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issues.

Authors: F Wolfe; K Michaud; E M Dewitt
Journal: Ann Rheum Dis Date: 2004-11 Impact factor: 19.103

6 in total